I completely agree - every concerned shareholder should

New Post Public Reply Private Reply Replies (1) Message Board
thesmalls
I completely agree - every concerned shareholder should write Bill and convey their thoughts directly with respect to this unprofessional behavior below. If Bill condones it - then it will make my decision easier to move on.

I normally wouldnt even address a post such as this but when it comes as, once again, another defensive attack from what isis supoosed to be an ambassador for the brand/shareholders - one should respond and let other shareholders decide for themselves what type of mouthpiece is best for the company.

- I am not a "basher." Far from it. I am a stockholder with well into 8 figures and a cost basis that was steadilysteadily increasing until recently. You dont want me to sell. PPS cant absorb the constant selling from VNDM now and which IR seems to have no answers for.

- My concern is (was?) directly with the handling of information or lack thereof with IR/muse. That seems to be rather obvious with most of the readers on here. The concerns seem genuinely mutual with the heart of my issues. If you take that as "bashing" then you/your organization need to really brush up on your understanding of the OTC dynamics, manipulation, and what real "bashers" do and how they manipulate. Based on the preponderence of evidence and circumstance combined with the stock price before/after IR took over and the emergence of dilutive MMs - it looks more like a "pump n dump" on your part than bashing on mine. DD and asking for direct answers in a public disclosure format IS NOT bashing. It is due diligence which is even more critical in this realm. You are a penny stock that is now back in trips - NOT a blue chip. Understand the difference.

- You /the company STILL refuse to address the critical questions that have been asked and "skirted" around and caused myself and others to show public concern:

1. What is the name of your firm? (Why in the world would this be confidential - goes sfraight to credibility and transparency for investors)

2. How are you compensated? This goes straight to bias/vested interest. Very straightforward and you have given conflicting answers. This should NOT be a secret. Goes straight to credibility based on bias. Granted - paid agents of former toxic lenders were disruptive of CCs, Timken, etc.

3. Guidance on revenue. Again - very different from what you are responding to. Bill provided very specific goals/targets in biz plan that has since been abolished and being reconstructed in 90 day plan. What is 2016 year end guidance range and/or when will IR/company provide it. Announcing SLAs 12-24 months out that may or may not come to fruition is NOT the same as saying: "We expect revenues to be between $500K and $2.5MM in 2016. Tighter guidance is not prudent at this time due to the nature of being a start up and the switching of revenue generation from in house to 3rd party licensing/SLA agreements." Straightforward. Real numbers. Not esoteric numbers with no definitive terms or contracts with teeth. Why is this difficult? Why keep ignoring the real question? I have been specific. Bill gave a 5 year revenue projection in biz plan along with decreasing OS that many long term investors considered the "fundamentals ". What are those new fundamentals and/or when will they specifically be updated? If these agreements and deals are specific in terms of start dates and production values - baselines should be straightforward on the minimum side of guidance.

I will address others later due to time constraints now.

You are quickly losing credibility trying to dismiss my valid concerns by lumping me in with them is rather silly when looking at my entire posting history here and elsewhere let alone completely unprofessional and flat out wrong. Worse, when you have an actual, long term investor that has been rather complimentary to the company at large over the last 12-24 months ask critical questions and then lambast me as a basher - you actually provide easy fodder for the real detractors on iLie to have a field day with your comments. If you arent going to address the specific questions and concerns above - do us all a favor and say nothing. I and other long term shareholders that i personally correspond with cant help but notice the direct correlation between the stock price and your emergence. Worse, the price spike prior to VNDM showing up and continually unloading shares driving the price down (again - fodder for the P&D argument).

For other concerned shareholders, I suggest you write to CEO directly if you find this type of response unproductive, unprofessional, and counter intuitive to the role that seems to be regular IR groups. Alienating long term investors with critical questions is NOT conducive to fostering respect, loyalty, and creating long term holders. Having me sell and move on tanks the price and forces others to sell. That imbalance from a large shareholder leaving becomes easy fodder for MM to naked short with little risk. How exactly does that strengthen the company and/or help shareholders...?

Again - if you are concerned as I am - go to Bill directly.



"Greetings TPAC Shareholders.

There are “shareholder concern” posts on places like IHUB and now Investors Hang Out. (In particular addressing the alias – thesmalls-- on Investors Hangout)

The post states that TPAC/IR skirts around revenue inquiries (among a list of other things that won’t be addressed here). This is so far from the truth. The IH subscriber that posted such information has made inaccurate and false accusations. The post stated that there is a disconnect. I would like for this to truly be a disconnect but I am now sure it isn’t.

It has been approved by CEO Bill McKay, as of May 4th, that IR can release deal structure information for the following forms of business dealings during the reconstruction:

• All contracts, of type purchase orders, Licensing Agreements, Service Level Agreements, PF Share agreements/distributions and OS structure information.

IR has tweeted that we could not extract information prior to the reconstruction period however since then we have provided direct information when requested for:
• O/S directly from the TA
• Deal structure including revenue time frame Licensing Agreement
• Deal Structure including revenue time frame Service Level Agreement

The revenue standard has been lowered from $250K to $75K (which should be restored)

IR has even provided news on Request for Quotes.

This is a new standard for TPAC"

Trans-Pacific Aerospace (TPAC) Stock Research Links

TPAC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 2

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 2

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 2

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 4

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Dylan Media Challenges CLIQ Digital's Proposed Share Buyback

Updated Category News Views 176

CLIQ Digital AG Faces Critical Vote from Major Shareholder CLIQ Digital AG, a well-known entity in the digital services industry, recently found itself at a pivotal moment. Dylan Media B.V., the largest shareholder in CLIQ Digital, has made headlines by declaring its intent to vote against a significant item on the agenda at the upcoming Annual General Meeting. This...

Continue Reading
CW Bancorp Announces Quarterly Dividend for Shareholders

Updated Category News Views 213

CW Bancorp Declares a Refreshing Quarterly Dividend CW BANCORP (OTCQX: CWBK), the parent company of CommerceWest Bank, recently announced the approval of a quarterly cash dividend by its Board of Directors. This step signifies the company's ongoing dedication to maximizing shareholder value. The Board declared a cash dividend of $0.23 per common share, illustrating the...

Continue Reading
Celebrating 5 Years: Legacy Leaders at HBCU ELI Shine Bright

Updated Category News Views 209

HBCU Executive Leadership Institute: Five Years of Excellence The HBCU Executive Leadership Institute at Clark Atlanta University has reached a significant milestone, celebrating its fifth anniversary. This program is dedicated to nurturing and developing the next generation of presidents and executives at Historically Black Colleges and Universities (HBCUs). It is an...

Continue Reading
Kuehn Law Investigates StubHub Holdings for Shareholder Rights

Updated Category News Views 103

Kuehn Law Investigates StubHub Holdings for Shareholder Rights NEW YORK – Kuehn Law, PLLC, a law firm dedicated to shareholder litigation, is focused on examining whether certain officers and directors at StubHub Holdings, Inc. (NYSE: STUB) have acted against the interests of shareholders. The firm’s investigation is driven by allegations in a federal securities...

Continue Reading
A Comprehensive Guide to Hard Money Lenders in Real Estate Financing

Updated Category Real Estate Views 690

In real estate financing, money lenders occupy a distinctive niche. They offer alternative funding solutions that diverge from traditional banking institutions. A hard money lender presents a viable option for those seeking quick access to capital or needing help securing loans through conventional means. Comprehending the nuances of this financing avenue is paramount...

Continue Reading